A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS
Publication
, Conference
McHutchison, JG; Shiffman, ML; Terrault, N; Manns, MP; Di Bisceglie, AM; Jacobson, IM; Afdhal, NH; Heathcote, EJ; Zeuzem, S; Reesink, HW ...
Published in: HEPATOLOGY
October 1, 2008
Duke Scholars
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2008
Volume
48
Issue
4
Start / End Page
431A / 432A
Location
San Francisco, CA
Publisher
JOHN WILEY & SONS INC
Conference Name
59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
McHutchison, J. G., Shiffman, M. L., Terrault, N., Manns, M. P., Di Bisceglie, A. M., Jacobson, I. M., … Muir, A. J. (2008). A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS. In HEPATOLOGY (Vol. 48, pp. 431A-432A). San Francisco, CA: JOHN WILEY & SONS INC.
McHutchison, John G., Mitchell L. Shiffman, Norah Terrault, Michael P. Manns, Adrian M. Di Bisceglie, Ira M. Jacobson, Nezom H. Afdhal, et al. “A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS.” In HEPATOLOGY, 48:431A-432A. JOHN WILEY & SONS INC, 2008.
McHutchison JG, Shiffman ML, Terrault N, Manns MP, Di Bisceglie AM, Jacobson IM, et al. A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS. In: HEPATOLOGY. JOHN WILEY & SONS INC; 2008. p. 431A-432A.
McHutchison, John G., et al. “A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS.” HEPATOLOGY, vol. 48, no. 4, JOHN WILEY & SONS INC, 2008, pp. 431A-432A.
McHutchison JG, Shiffman ML, Terrault N, Manns MP, Di Bisceglie AM, Jacobson IM, Afdhal NH, Heathcote EJ, Zeuzem S, Reesink HW, George S, Adda N, Muir AJ. A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS. HEPATOLOGY. JOHN WILEY & SONS INC; 2008. p. 431A-432A.
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2008
Volume
48
Issue
4
Start / End Page
431A / 432A
Location
San Francisco, CA
Publisher
JOHN WILEY & SONS INC
Conference Name
59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics